{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:10:01Z","timestamp":1750165801754,"version":"3.41.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202212"],"award-info":[{"award-number":["82202212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12282-025-01696-5","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:58:50Z","timestamp":1743825530000},"page":"740-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female"],"prefix":"10.1007","volume":"32","author":[{"given":"Ningning","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.55782\/ane-2011-1863","volume":"71","author":"J Durdiakova","year":"2011","unstructured":"Durdiakova J, Ostatnikova D, Celec P. Testosterone and its metabolites\u2013modulators of brain functions. Acta Neurobiol Exp (Wars). 2011;71:434\u201354.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"1696_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12672-023-00811-2","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Wang M, Hua M, Wang Z, Ying Y, Zhang Z, et al. Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study. Discov Oncol. 2023;14:198.","journal-title":"Discov Oncol"},{"key":"1696_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.eururo.2013.08.015","volume":"65","author":"J Klap","year":"2014","unstructured":"Klap J, Loughlin KR. Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014;65:115\u201323.","journal-title":"Eur Urol"},{"key":"1696_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1210\/jcem-53-1-58","volume":"53","author":"JF Dunn","year":"1981","unstructured":"Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53:58\u201368.","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000158055","volume":"3","author":"K Tiefenbacher","year":"2008","unstructured":"Tiefenbacher K, Daxenbichler G. The role of androgens in normal and malignant breast tissue. Breast Care (Basel). 2008;3:325\u201331.","journal-title":"Breast Care (Basel)"},{"issue":"Suppl 4","key":"1696_CR6","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0015-0282(02)02984-9","volume":"77","author":"ER Simpson","year":"2002","unstructured":"Simpson ER. Aromatization of androgens in women: current concepts and findings. Fertil Steril. 2002;77(Suppl 4):S6-10.","journal-title":"Fertil Steril"},{"issue":"Suppl 4","key":"1696_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3-5.","journal-title":"Fertil Steril"},{"issue":"Suppl 4","key":"1696_CR8","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0015-0282(02)02979-5","volume":"77","author":"C Dimitrakakis","year":"2002","unstructured":"Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril. 2002;77(Suppl 4):S26-33.","journal-title":"Fertil Steril"},{"issue":"3","key":"1696_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1210\/er.2003-0016","volume":"25","author":"W Somboonporn","year":"2004","unstructured":"Somboonporn W, Davis SR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev. 2004;25(3):374\u201388.","journal-title":"Endocr Rev"},{"key":"1696_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239\u201357.","journal-title":"Br J Cancer"},{"issue":"3","key":"1696_CR11","first-page":"389","volume":"1967","author":"OH Iversen","year":"1965","unstructured":"Iversen OH. Kinetics of cellular proliferation and cell loss in human carcinomas. A discussion of methods available for in vivo studies. Eur J Cancer. 1965;1967(3):389\u201394.","journal-title":"Eur J Cancer"},{"key":"1696_CR12","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr3438","volume":"15","author":"ES Schernhammer","year":"2013","unstructured":"Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, et al. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Res. 2013;15:R46.","journal-title":"Breast Cancer Res"},{"key":"1696_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ijc.11034","volume":"105","author":"H Yu","year":"2003","unstructured":"Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, et al. Plasma sex steroid hormones and breast cancer risk in Chinese women. Int J Cancer. 2003;105:92\u20137.","journal-title":"Int J Cancer"},{"key":"1696_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jnci\/djr031","volume":"103","author":"GN Farhat","year":"2011","unstructured":"Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst. 2011;103:562\u201370.","journal-title":"J Natl Cancer Inst"},{"key":"1696_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.maturitas.2013.08.002","volume":"76","author":"RL Glaser","year":"2013","unstructured":"Glaser RL, Dimitrakakis C. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. Maturitas. 2013;76:342\u20139.","journal-title":"Maturitas"},{"key":"1696_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.maturitas.2015.02.259","volume":"81","author":"R Glaser","year":"2015","unstructured":"Glaser R, Dimitrakakis C. Reduced incidence of breast cancer in women adherent to testosterone or testosterone-anastrozole hormone therapy: updated interim analysis. Maturitas. 2015;81:189.","journal-title":"Maturitas"},{"key":"1696_CR17","doi-asserted-by":"publisher","first-page":"djt319","DOI":"10.1093\/jnci\/djt319","volume":"106","author":"FE Vera-Badillo","year":"2014","unstructured":"Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:djt319.","journal-title":"J Natl Cancer Inst"},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/modpathol.2011.54","volume":"24","author":"LC Collins","year":"2011","unstructured":"Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study. Mod Pathol. 2011;24:924\u201331.","journal-title":"Mod Pathol"},{"key":"1696_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26:252\u20138.","journal-title":"Nat Med"},{"key":"1696_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009887","volume":"18","author":"BL Hayes","year":"2022","unstructured":"Hayes BL, Robinson T, Kar S, Ruth KS, Tsilidis KK, Frayling T, et al. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendel Randomization Study PLoS Genet. 2022;18: e1009887.","journal-title":"A Mendel Randomization Study PLoS Genet"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52:572\u201381.","journal-title":"Nat Genet"},{"key":"1696_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41416-021-01392-z","volume":"125","author":"S Tin Tin","year":"2021","unstructured":"Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. Br J Cancer. 2021;125:126\u201334.","journal-title":"Br J Cancer"},{"key":"1696_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13058-022-01553-9","volume":"24","author":"A Nounu","year":"2022","unstructured":"Nounu A, Kar SP, Relton CL, Richmond RC. Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study. Breast Cancer Res. 2022;24:66.","journal-title":"Breast Cancer Res"},{"key":"1696_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol. 2014;5:412\u201324.","journal-title":"World J Clin Oncol"},{"issue":"12","key":"1696_CR25","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3390\/genes13122332","volume":"13","author":"E Ermis Akyuz","year":"2022","unstructured":"Ermis Akyuz E, Bell SM. The diverse role of CUB and sushi multiple domains 1 (CSMD1) in human diseases. Genes. 2022;13(12):2332.","journal-title":"Genes"},{"issue":"2","key":"1696_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/genes12020162","volume":"12","author":"SJ Burgess","year":"2021","unstructured":"Burgess SJ, Gibbs H, Toomes C, Coletta PL, Bell SM. The role of csmd1 during mammary gland development. Genes. 2021;12(2):162.","journal-title":"Genes"},{"key":"1696_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/or.2017.5656","volume":"38","author":"M Kamal","year":"2017","unstructured":"Kamal M, Holliday DL, Morrison EE, Speirs V, Toomes C, Bell SM. Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. Oncol Rep. 2017;38:283\u201392.","journal-title":"Oncol Rep"},{"key":"1696_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4161\/cbt.8.10.8132","volume":"8","author":"C Ma","year":"2009","unstructured":"Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther. 2009;8:907\u201316.","journal-title":"Cancer Biol Ther"},{"key":"1696_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13058-022-01524-0","volume":"24","author":"H Chen","year":"2022","unstructured":"Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, et al. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci. Breast Cancer Res. 2022;24:27.","journal-title":"Breast Cancer Res"},{"key":"1696_CR30","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-14-2012","volume":"75","author":"J Stone","year":"2015","unstructured":"Stone J, Thompson DJ, Dos Santos SI, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75:2457\u201367.","journal-title":"Cancer Res"},{"key":"1696_CR31","doi-asserted-by":"publisher","first-page":"16000","DOI":"10.1038\/s41598-018-34290-1","volume":"8","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Yamamoto S, Sakaguti S, Isayama K, Oka M, Nagano H, et al. A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERalpha expression. Sci Rep. 2018;8:16000.","journal-title":"Sci Rep"},{"key":"1696_CR32","doi-asserted-by":"publisher","first-page":"D1179","DOI":"10.1093\/nar\/gkac821","volume":"51","author":"M Lu","year":"2023","unstructured":"Lu M, Zhang Y, Yang F, Mai J, Gao Q, Xu X, et al. TWAS Atlas: a curated knowledgebase of transcriptome-wide association studies. Nucleic Acids Res. 2023;51:D1179\u201387.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"1696_CR33","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.3390\/molecules25214967","volume":"25","author":"B Zaharija","year":"2020","unstructured":"Zaharija B, Samard\u017eija B, Bradshaw NJ. The TRIOBP isoforms and their distinct roles in actin stabilization, deafness, mental illness, and cancer. Molecules. 2020;25(21):4967.","journal-title":"Molecules"},{"key":"1696_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.heares.2016.12.017","volume":"347","author":"M Wesdorp","year":"2017","unstructured":"Wesdorp M, van de Kamp JM, Hensen EF, Schraders M, Oostrik J, Yntema HG, et al. Broadening the phenotype of DFNB28: mutations in TRIOBP are associated with moderate, stable hereditary hearing impairment. Hear Res. 2017;347:56\u201362.","journal-title":"Hear Res"},{"key":"1696_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.canlet.2014.08.005","volume":"356","author":"J Bao","year":"2015","unstructured":"Bao J, Wang S, Gunther LK, Kitajiri S, Li C, Sakamoto T. The actin-bundling protein TRIOBP-4 and -5 promotes the motility of pancreatic cancer cells. Cancer Lett. 2015;356:367\u201373.","journal-title":"Cancer Lett"},{"key":"1696_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2018.04.008","volume":"12","author":"H Wang","year":"2018","unstructured":"Wang H, Li K, Mei Y, Huang X, Li Z, Yang Q, et al. Sp1 suppresses miR-3178 to promote the metastasis invasion cascade via upregulation of TRIOBP. Mol Ther Nucleic Acids. 2018;12:1\u201311.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1696_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mce.2018.07.003","volume":"489","author":"M Tsachaki","year":"2019","unstructured":"Tsachaki M, Odermatt A. Subcellular localization and membrane topology of 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol. 2019;489:98\u2013106.","journal-title":"Mol Cell Endocrinol"},{"key":"1696_CR38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1210\/er.2018-00020","volume":"39","author":"DJ Handelsman","year":"2018","unstructured":"Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 2018;39:803\u201329.","journal-title":"Endocr Rev"},{"key":"1696_CR39","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2023-0181","volume":"47","author":"X Shi","year":"2024","unstructured":"Shi X, Bu A, Yang Y, Wang Y, Zhao C, Fan J, et al. Investigating the shared genetic architecture between breast and ovarian cancers. Genet Mol Biol. 2024;47: e20230181.","journal-title":"Genet Mol Biol"},{"key":"1696_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.maturitas.2015.06.002","volume":"82","author":"R Glaser","year":"2015","unstructured":"Glaser R, Dimitrakakis C. Testosterone and breast cancer prevention. Maturitas. 2015;82:291\u20135.","journal-title":"Maturitas"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-025-01696-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:44:57Z","timestamp":1750164297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-025-01696-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s12282-025-01696-5","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"type":"print","value":"1340-6868"},{"type":"electronic","value":"1880-4233"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Our analysis is based on publicly available GWAS summary-level data, so no additional ethical approval is required for this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}